Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06479980 · ClinicalTrials.gov registry record · NA

Single Session Narrative Therapy Study

A NA study of HIV and Substance Use, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06479980 is a NA study of HIV and Substance Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 60 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06479980, a NA study of HIV and Substance Use, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This pilot research study will provide timely access to behavioral health services through the provision of a single-session narrative therapy intervention. The goal of this 6-month study is to test the acceptability, feasibility, and fit of the intervention in an integrated primary care clinic serving people living with HIV.

Interventions

  • BEHAVIORAL Single Session Narrative Therapy

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-06-04
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT06479980

The ClinicalTrials.gov registry entry for NCT06479980 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (86% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Single Session Narrative Therapy is the first listed.

NCT06479980 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06479980 about?

NCT06479980 is a clinical study titled "Single Session Narrative Therapy Study". This pilot research study will provide timely access to behavioral health services through the provision of a single-session narrative therapy intervention. The goal of this 6-month study is to test the acceptability, feasibility, and fit of the intervention in an integrated primary care clinic serv...

What is the current status of trial NCT06479980?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-06-04. Estimated completion is 2025-12-31.

What conditions does trial NCT06479980 study?

This clinical trial studies the following conditions: HIV, Substance Use, Mental Health Issue.

What interventions are being tested in trial NCT06479980?

The interventions under investigation include: Single Session Narrative Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06479980?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06479980 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.